Home Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.
 

Keywords :   


Jefferies Group Reiterates Hold Rating for Gilead Sciences, Inc.

2016-03-27 07:36:47| Biotech - Topix.net

's stock had its "hold" rating reiterated by investment analysts at Jefferies Group in a report issued on Monday, Market Beat Ratings reports. They currently have a $97.00 price target on the biopharmaceutical company's stock, down from their prior price target of $100.00.

Tags: inc group rating hold

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11Idées de CADRES No.83
23.11 12BOX PREMIUMpack 25th
23.11V2box
23.11
23.11 &
23.11DVD('97/)E11387
23.117
23.11
More »